Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TGR5 is a G protein-coupled receptor that acts as a cell-surface sensor for bile acids, eliciting second messenger signaling cascades. Activation leads to increased intracellular cAMP via adenylyl cyclase activation. Key roles include regulation of energy homeostasis, induction of glucagon-like peptide‑1 (GLP‑1) secretion, modulation of inflammation, and cytoprotective properties during cholestasis. It is a potential target for treatment of metabolic diseases, cholestatic liver diseases, and portal hypertension.
Gs protein activation leading to increased intracellular cAMP via adenylyl cyclase activation and triggering downstream pathways including MAP kinase signaling.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-protein Coupled Bile Acid Receptor TGR5 (TGR5).